Product Details
Product Details
Product Specification
Antibody Type | ADC |
Concentration | 1 mg/ml |
Endotoxin | <1EU/mg |
Physical Appearance | Liquid |
Storage Buffer | Reconstitute the Trastuzumab emtansine using 0.9% Sodium Chloride Injection |
Stability & Storage |
2 to 8 °C for 2 weeks under sterile conditions; -20 °C for 3 months under sterile conditions; -80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.
|
Background
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer
